P

Inventor

LOOSMORE SHEENA M

CA45 patents
⚠️ This page may combine multiple inventors who share the name “LOOSMORE SHEENA M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CONNAUGHT LAB

26 patents
US5808024ASep 15, 1998

Nucleic acids encoding high molecular weight major outer membrane protein of moraxella

CONNAUGHT LAB36 citations96
US5085862AFeb 4, 1992

Genetic detoxification of pertussis toxin

CONNAUGHT LAB83 citations95
US6147057ANov 14, 2000

Analog of Haemophilus Hin47 with reduced protease activity

CONNAUGHT LAB17 citations93
US6114125ASep 5, 2000

Analog of Haemophilus Hin47 with reduced protease activity

CONNAUGHT LAB17 citations93
US6025342AFeb 15, 2000

Analog of Haemophilus Hin47 with reduced protease activity

CONNAUGHT LAB19 citations93
US5981503ANov 9, 1999

Analog of Haemophilus Hin47 with reduced protease activity

CONNAUGHT LAB19 citations93
US5939297AAug 17, 1999

Analog of haemophilus HIN47 with reduced protease activity

CONNAUGHT LAB20 citations93
US5935573AAug 10, 1999

Method of use of an analog of Haemophilus influenzae Hin47 with reduced protease activity

CONNAUGHT LAB19 citations93
US5869302AFeb 9, 1999

Analog of haemophilus hin47 with reduced protease activity

CONNAUGHT LAB21 citations93
US5656436AAug 12, 1997

Analog of Haemophilus Hin47 with reduced protease activity

CONNAUGHT LAB20 citations93
US5506139AApr 9, 1996

Analog of haemophilus Hin47 with reduced protease activity

CONNAUGHT LAB27 citations93
US5433945AJul 18, 1995

Immunoprotective genetically-detoxified mutants of pertussis toxin

CONNAUGHT LAB29 citations92
US5358868AOct 25, 1994

Genetic detoxification of pertussis toxin

CONNAUGHT LAB46 citations92
US5332583AJul 26, 1994

Vaccine containing genetically-detoxified pertussis holotoxin

CONNAUGHT LAB28 citations92
US5244657ASep 14, 1993

Genetic detoxification of pertussis toxin

CONNAUGHT LAB29 citations92
US5221618AJun 22, 1993

Genetic detoxification of pertussis toxin

CONNAUGHT LAB32 citations92
US5665353ASep 9, 1997

Composition containing an analog of haemophilus Hin47 with reduced protease activity

CONNAUGHT LAB17 citations82
US6090576AJul 18, 2000

DNA encoding a transferrin receptor of Moraxella

CONNAUGHT LAB15 citations81
US5977337ANov 2, 1999

Lactoferrin receptor genes of Moraxella

CONNAUGHT LAB7 citations72
US6140082AOct 31, 2000

Expression of gene products from genetically manipulated strains of bordetella

CONNAUGHT LAB5 citations70
US5942418AAug 24, 1999

Expression of gene products from genetically manipulated strains of Bordetella

CONNAUGHT LAB7 citations69
US7118749B2Oct 10, 2006

Transferrin receptor genes

CONNAUGHT LAB4 citations62
US5998168ADec 7, 1999

Expression of gene products from genetically manipulated strains of bordetella

CONNAUGHT LAB2 citations59
US5932714AAug 3, 1999

Expression of gene products from genetically manipulated strains of Bordetella

CONNAUGHT LAB1 citations59
US6054123AApr 25, 2000

Haemophilus influenzae dimethylsulphoxide reductase enzyme

CONNAUGHT LAB1 citations52
US6184371B1Feb 6, 2001

Lactoferrin receptor genes of Moraxella

CONNAUGHT LAB1 citations50

AVENTIS PASTEUR

15 patents
US7241449B1Jul 10, 2007

Transferrin receptor genes of moraxella

AVENTIS PASTEUR10 citations83
US6440424B1Aug 27, 2002

High molecular weight major outer membrane protein of moraxella

AVENTIS PASTEUR10 citations74
US6440425B1Aug 27, 2002

High molecular weight major outer membrane protein of moraxella

AVENTIS PASTEUR11 citations74
US6391313B1May 21, 2002

Multi-component vaccine to protect against disease caused by Haemophilus influenzae and Moraxella catarrhalis

AVENTIS PASTEUR7 citations74
US6437096B1Aug 20, 2002

Transferrin receptor of moraxella

AVENTIS PASTEUR5 citations73
US6974581B1Dec 13, 2005

Multi-component vaccine comprising at least two antigens from haemophilus influenzae to protect against disease

AVENTIS PASTEUR2 citations63
US6448386B2Sep 10, 2002

High molecular weight major outer membrane protein of moraxella

AVENTIS PASTEUR4 citations63
US6432669B1Aug 13, 2002

Protective recombinant Haemophilus influenzae high molecular weight proteins

AVENTIS PASTEUR2 citations63
US6342232B1Jan 29, 2002

Multi-component vaccine comprising at least three antigens to protect against disease cased by Haemophilus influenzae

AVENTIS PASTEUR6 citations63
US6440701B1Aug 27, 2002

Transferrin receptor genes of Moraxella

AVENTIS PASTEUR2 citations62
US6361779B1Mar 26, 2002

Transferrin receptor genes

AVENTIS PASTEUR2 citations62
US6358727B1Mar 19, 2002

Haemophilus transferrin receptor genes

AVENTIS PASTEUR2 citations62
US7015033B1Mar 21, 2006

Co-expression of recombination proteins

AVENTIS PASTEUR0 citations52
US6849447B2Feb 1, 2005

Protective recombinant Haemophilus influenzae high molecular weight proteins

AVENTIS PASTEUR0 citations52
US6335182B1Jan 1, 2002

Recombinant Haemophilus influenzae adhesin proteins

AVENTIS PASTEUR1 citations52

(unassigned)

2 patents

CONNAUGHT LABORATRIES LIMITED

1 patent

SANOFI PASTEUR LTD

1 patent